Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/30/2025

Factors Affecting Immunoglobulin Levels

Primary Immunodeficiency Disorders

  • Agammaglobulinemia causes very low or undetectable immunoglobulins with absent or severely reduced B cells, typically presenting in the first 2 years of life with recurrent bacterial respiratory infections 1
  • Common Variable Immunodeficiency (CVID) produces variable reduction in ≥2 immunoglobulin classes with normal or moderately reduced B-cell numbers, often diagnosed after age 4 years 1
  • Selective IgA Deficiency is defined by IgA <7 mg/dL with normal IgG and IgM levels in patients older than 4 years, affecting approximately 1 in 300-700 white individuals 1
  • IgG subclass deficiencies can occur with normal total IgG levels but deficiency in one or more subclasses (IgG1-4), though approximately 2.5% of the population will automatically be "deficient" in at least one subclass by statistical definition 1

Immunosuppressive Medications

  • Antiepileptic drugs (phenytoin, carbamazepine, valproic acid, zonisamide) can cause reversible selective IgA deficiency and hypogammaglobulinemia 2

Protein Loss Syndromes

  • Nephrotic syndrome causes hypogammaglobulinemia due to urinary protein loss, diagnosed by 24-hour urine protein, urine protein/creatinine ratio, and urinalysis 2
  • Protein-losing enteropathy results in gastrointestinal protein loss with chronic diarrhea, assessed by stool alpha-1 antitrypsin clearance and intestinal imaging 2
  • Lymphatic disorders disrupt lymphatic drainage leading to protein loss 2
  • A critical distinguishing feature is that albumin and total protein levels will also be low in protein loss syndromes, unlike true immunodeficiency where only immunoglobulins are affected 2

Autoimmune Diseases and Inflammatory Conditions

  • Waldenström macroglobulinemia causes monoclonal IgM elevation, with treatment indicated when IgM levels exceed 60 g/L due to imminent risk of symptomatic hyperviscosity 3
  • Systemic lupus erythematosus (SLE) patients show variable immunoglobulin changes after pneumococcal vaccination, with some studies showing IgG and IgA levels decreasing by day 28 post-vaccination, though remaining in normal range 4
  • Good syndrome (thymoma-associated immunodeficiency) presents with late-onset combined immunodeficiency phenotype similar to CVID but with thymoma present 2
  • High erythrocyte sedimentation rate (ESR), high SLEDAI scores, and active disease correlate with poor immunological responses to vaccination in SLE patients 4
  • IgG4 is present in very low concentrations in children younger than 10 years, and therefore IgG4 deficiencies should not be diagnosed before age 10 years 1
  • Older age correlates with poorer post-immunization antibody titers (r=0.30, p=0.02) 4
  • Earlier disease onset in SLE correlates with poorer immunological response (r=0.43, p=0.02) 4

Clinical Monitoring Considerations

  • Prior to administering intravenous immunoglobulin (IVIG), serum immunoglobulin levels must be measured because patients with selective IgA deficiency may develop anaphylactic reactions, and pre-existing hypergammaglobulinemia may become aggravated leading to hyperviscosity 5, 6
  • Rituximab can cause a transient increase in serum IgM in 30-80% of patients, which may exacerbate hyperviscosity symptoms but doesn't indicate treatment failure 3
  • Prednisolone dosage is statistically associated with low antibody response to pneumococcal vaccination 4